The global burden of chronic kidney disease (CKD) has been increasing. From 1990 to 2016, the incidence and prevalence of CKD have increased by nearly 90%, and death from CKD has increased by almost 100%.1 In 2017, the global prevalence of CKD was estimated at 9.1%, affecting 697.5 million people.2 The CKD burden is disproportionately higher in low- and lower-middle-income countries.1 However, ~80% of patients with kidney failure receiving kidney replacement therapy (KRT) live in affluent countries that represent only 12% of the world population.